HB 356 Utah House · 2026 General Session

Drug Distribution Amendments

HB 356 clarifies Utah's rules for the federal 340B drug discount program, which provides discounted medications to eligible healthcare organizations. It defines key terms like "340B covered entity" (e.g., hospitals or clinics participating in the federal program) and prohibits drug manufacturers from restricting contracts between pharmacies and these entities or requiring excessive data sharing beyond federal requirements. The bill directly affects 340B-covered entities, pharmacies, and drug manufacturers by ensuring they cannot interfere with program participation or impose unnecessary conditions. It makes technical updates to Utah law without new funding, aligning state rules with federal program standards.
Bill status signed all 5 stages cleared
Introduction
Jan 2026
Committee Review
Feb 2026
House Passage
Feb 2026
Senate Passage
Feb 2026
Signed into Law
Feb 2026
Introduced Jan 26, 2026 Signed Feb 27, 2026
Maddy AI version diff · 1 comparison

What changed between versions

Introduced Enrolled · 4 edits · Feb 27, 2026
MODERATE
This bill establishes state laws prohibiting pharmaceutical manufacturers from restricting how pharmacies contract with 340B covered entities or interfering with the delivery of discounted drugs. It defines key terms like '340B covered entity' and 'contracted pharmacy' to clarify the rules. The legislation also includes a specific provision allowing the state's public employee benefit program to adjust its practices to handle any financial impacts from these new restrictions.
Scope change
The bill applies to pharmaceutical manufacturers and pharmacies operating within Utah, specifically regulating interactions between manufacturers and 340B covered entities.
REQUIREMENT

Prohibits manufacturers from restricting pharmacy contracts, denying access to drugs, or interfering with the delivery and reimbursement of 340B eligible drugs.

DEFINITION

Defines critical terms including '340B covered entity', '340B eligible drug', 'contracted pharmacy', 'manufacturer', and 'pharmacy'.

ENFORCEMENT

Mandates that the Public Employees' Benefit and Insurance Program adjust its business practices to mitigate financial impacts caused by the new prohibitions.

TECHNICAL

Updates formatting and punctuation in the statutory text to conform to current legislative standards.

Floor votes · Senate Feb 19, 2026 · House Feb 4, 2026

How they voted

250
Passed · 4 other
Total votes 29
Feb 19, 2026
D Democratic6
6 Yea
100% Yea
N Forward1
1 Yea
100% Yea
R Republican22
18 Yea 4
81% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
38
Key actions
10
Committee
7
Feb 27, 2026
Signed into law
Governor Signed
executive
Feb 19, 2026
Lower · Passed
House/ signed by Speaker/ sent for enrolling
lower
Feb 19, 2026
Lower · Passed
Senate/ signed by President/ returned to House
lower
Feb 19, 2026
Upper · Passed
Senate/ passed 3rd reading
upper
Feb 17, 2026
Upper · Passed
Senate/ committee report favorable [Senate Health and Human Services Committee]
upper
Feb 12, 2026
Upper · Passed
Senate Comm - Favorable Recommendation [Senate Health and Human Services Committee]
upper
Feb 6, 2026
Committee
Senate/ to standing committee [Senate Health and Human Services Committee]
upper
Feb 4, 2026
Introduced
Senate/ 1st reading (Introduced)
upper
Feb 4, 2026
Upper · Passed
House/ passed 3rd reading
upper
Feb 2, 2026
Lower · Passed
House/ comm rpt/ placed on Consent Calendar [House Health and Human Services Committee]
lower
Jan 30, 2026
Lower · Passed
House Comm - Consent Calendar Recommendation [House Health and Human Services Committee]
lower
Jan 30, 2026
Lower · Passed
House Comm - Favorable Recommendation [House Health and Human Services Committee]
lower
Jan 30, 2026
Committee
House/ to standing committee [House Health and Human Services Committee]
lower
Jan 26, 2026
Introduced
House/ 1st reading (Introduced)
lower
1 primary · 1 co-sponsor

Sponsors